Pediatric COVID-19 Vaccine Study
Help pursue longer lasting protection against COVID-19
While most children do not become seriously ill from COVID-19, some do and require hospitalization. Children can still infect others and may be at risk of developing MIS-C, a rare but life-threatening inflammatory condition related to COVID-19. As new variants and subtypes continue to emerge, approval of a bivalent vaccine for children that effectively targets both current and future variants will be key for protecting them against COVID-19.
This study may be an option for infants and children who:
Are 6 months to less than 4 years and 3 months old
Are generally healthy or have stable chronic medical conditions
Have not received a COVID-19 vaccine
A study team member will help determine if this study is right for your child based on all participation criteria. Parents/guardians may be reimbursed for expenses related to participants’ time in the study. Contact a study member to learn more!
